Hangzhou Tigermed Consulting Co Ltd (300347):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Hangzhou Tigermed Consulting Co Ltd (300347) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8145
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hangzhou Tigermed Consulting Co Ltd (Hangzhou Tigermed) is a contract research organization that provides professional clinical trial services. The organization offers preclinical, clinical trials, registration and regulation; and other services. Its clinical trial services include monitoring, medical writing, data management, biostatic analysis, and QA services, on-site management and clinical operation services for study sites or investigators. Hangzhou Tigermed conducts research in the areas of virology, cardiology and oncology. The organization also offers medical imaging, central lab, medical monitor, scientific affair, pharmacovigilance, cold-chain transportation, non-interventional study, and EDC system services. It provides outsourced services for biotechnology, medical devices and pharmaceuticals companies. The organization operates through its offices located in China, Taiwan, India, Korea, Australia, Hong Kong, the US, Canada, Japan, Malaysia and Singapore. Hangzhou Tigermed is headquartered in Hangzhou, China.

Hangzhou Tigermed Consulting Co Ltd (300347) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hangzhou Tigermed Consulting Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
CMAB Biopharma Raises USD34 Million in Series B Financing 12
ZAI Labs Raises More Than USD30 Million in Series A Venture Financing 13
Partnerships 15
Hangzhou Tigermed Consulting Enters into Agreement with EPS Holdings 15
Zhejiang Jiuzhou Pharma forms Joint Venture with Frontage Labs 16
Hangzhou Tigermed and Dian Diagnostics Form Joint Venture 17
Equity Offering 18
Hangzhou Tigermed Consulting Raises USD91.29 million in Private Placement of Shares 18
Hangzhou Tigermed Consulting Raises USD91 Million in Private Placement of Shares 19
Hangzhou Tigermed to Raise up to USD80.5 Million in Private Placement of Shares 20
Hangzhou Tigermed Consulting Completes IPO For US$80 Million 21
Acquisition 22
Frontage Laboratories Acquires Concord Biosciences 22
Hangzhou Tigermed to Acquire 70% Stake in DreamCIS for USD24 Million 23
Hangzhou Tigermed Completes Acquisition of Majority Stake in Frontage Labs for USD50.2 Million 24
Hangzhou Tigermed Consulting Co Ltd – Key Competitors 25
Hangzhou Tigermed Consulting Co Ltd – Key Employees 26
Hangzhou Tigermed Consulting Co Ltd – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Joint Venture 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hangzhou Tigermed Consulting Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Hangzhou Tigermed Consulting Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CMAB Biopharma Raises USD34 Million in Series B Financing 12
ZAI Labs Raises More Than USD30 Million in Series A Venture Financing 13
Hangzhou Tigermed Consulting Enters into Agreement with EPS Holdings 15
Zhejiang Jiuzhou Pharma forms Joint Venture with Frontage Labs 16
Hangzhou Tigermed and Dian Diagnostics Form Joint Venture 17
Hangzhou Tigermed Consulting Raises USD91.29 million in Private Placement of Shares 18
Hangzhou Tigermed Consulting Raises USD91 Million in Private Placement of Shares 19
Hangzhou Tigermed to Raise up to USD80.5 Million in Private Placement of Shares 20
Hangzhou Tigermed Consulting Completes IPO For US$80 Million 21
Frontage Laboratories Acquires Concord Biosciences 22
Hangzhou Tigermed to Acquire 70% Stake in DreamCIS for USD24 Million 23
Hangzhou Tigermed Completes Acquisition of Majority Stake in Frontage Labs for USD50.2 Million 24
Hangzhou Tigermed Consulting Co Ltd, Key Competitors 25
Hangzhou Tigermed Consulting Co Ltd, Key Employees 26
Hangzhou Tigermed Consulting Co Ltd, Other Locations 27
Hangzhou Tigermed Consulting Co Ltd, Subsidiaries 27
Hangzhou Tigermed Consulting Co Ltd, Joint Venture 27

List of Figures
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hangzhou Tigermed Consulting Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hangzhou Tigermed Consulting Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Hangzhou Tigermed Consulting Co Ltd (300347):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Yantai Jereh Oilfield Services Group Co Ltd (002353):石油・ガス:M&Aディール及び事業提携情報
    Summary Yantai Jereh Oilfield Services Group Co Ltd (Yantai Jereh), formerly Yantai Jereh Equipment Group Co Ltd is an integrated oil and gas company that manufactures, designs, and markets oilfield equipment. The company offers oil and gas field equipment such as drilling and workover rig, simulati …
  • Endress+Hauser AG:企業の戦略的SWOT分析
    Endress+Hauser AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Meridian Bancorp Inc (EBSB):企業の財務・戦略的SWOT分析
    Meridian Bancorp Inc (EBSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Data#3 Limited (DTL):企業の財務・戦略的SWOT分析
    Data#3 Limited (DTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Tien Phong Plastic (NTP):企業の財務・戦略的SWOT分析
    Tien Phong Plastic (NTP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Becton Dickinson and Co (BDX):企業の財務・戦略的SWOT分析
    Becton Dickinson and Co (BDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • 3M Company:企業の戦略・SWOT・財務分析
    3M Company - Strategy, SWOT and Corporate Finance Report Summary 3M Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Independence Group NL:企業のM&A・事業提携・投資動向
    Independence Group NL - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Independence Group NL Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Carmot Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company which discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company’s product portfolio encompasses investigational candidates in preclinical trials: peptide-small molecule h …
  • Hexion Inc.:企業の戦略・SWOT・財務分析
    Hexion Inc. - Strategy, SWOT and Corporate Finance Report Summary Hexion Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Innovative Solutions and Support, Inc.:企業の戦略・SWOT・財務分析
    Innovative Solutions and Support, Inc. - Strategy, SWOT and Corporate Finance Report Summary Innovative Solutions and Support, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Obuv Rossii OOO (OBUV):企業の財務・戦略的SWOT分析
    Obuv Rossii OOO (OBUV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • China Digital Culture (Group) Ltd (8175):企業の財務・戦略的SWOT分析
    China Digital Culture (Group) Ltd (8175) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on …
  • BrightSpring Health Services:企業の戦略・SWOT・財務分析
    BrightSpring Health Services - Strategy, SWOT and Corporate Finance Report Summary BrightSpring Health Services - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Evgen Pharma Plc (EVG):企業の財務・戦略的SWOT分析
    Summary Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a clinical-stage drug development company focused on the development of sulforaphane-based compounds for the treatment of cancer and neurological disease. Its pipeline product SFX-01 targets STAT3 signalling to inhibit stem-like c …
  • Venoco, LLC-石油・ガス分野:企業M&A・提携分析
    Summary Venoco, LLC (Venoco), formerly known as Venoco, Inc., is an independent energy company. It carries out acquisition, exploration, exploitation and development of oil and natural gas properties. The company’s major onshore and offshore properties are located in Southern California. Venoco offs …
  • Qantas Airways Limited:企業の戦略・SWOT・財務分析
    Qantas Airways Limited - Strategy, SWOT and Corporate Finance Report Summary Qantas Airways Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cornell University-医療機器分野:企業M&A・提携分析
    Summary Cornell University (CU) is an educational institute that offers graduate and undergraduate education and research services. The institute offers education in biological and environmental engineering, communication, crop and soil sciences, development sociology, biological statistics and comp …
  • Genocea Biosciences Inc (GNCA):企業の財務・戦略的SWOT分析
    Summary Genocea Biosciences Inc (Genocea), formerly Genocea Inc, is a cancer vaccines provider. The company discovers and develops T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. It provides Gen-009 and Gen-010 neoantigen cancer Vaccine pipeline.Genoceaatlas tec …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆